Catalyst Financial Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$383K Buy
4,495
+1,113
+33% +$99.2K 0.05% 245
2025
Q4
$267K Buy
3,382
+263
+8% +$20.6K 0.03% 268
2025
Q3
$249K Sell
3,119
-126
-4% -$10.7K 0.03% 266
2025
Q2
$295K Buy
3,245
+253
+8% +$23.1K 0.03% 237
2025
Q1
$280K Sell
2,992
-27
-0.9% -$2.42K 0.05% 226
2024
Q4
$274K Buy
3,019
+5
+0.2% +$477 0.05% 220
2024
Q3
$313K Buy
3,014
+152
+5% +$15.5K 0.06% 194
2024
Q2
$278K Buy
2,862
+281
+11% +$25.9K 0.06% 199
2024
Q1
$224K Sell
2,581
-231
-8% -$19.6K 0.06% 209
2023
Q4
$224K Sell
2,812
-59
-2% -$4.44K 0.06% 200
2023
Q3
$204K Buy
2,871
+53
+2% +$3.96K 0.07% 200
2023
Q2
$217K Buy
+2,818
New +$218K 0.08% 179

Other funds holding CL

Catalyst Financial Partners's CL Position: Q1 2026 in Review

Catalyst Financial Partners increased its Colgate-Palmolive (CL) stake by 33% in Q1 2026, buying an estimated $99.2K and bringing the position to 4,495 shares worth $383K. The position accounts for 0.05% of the portfolio, ranked #245.

Catalyst Financial Partners first reported a position in CL in Q2 2023 and has held it in 12 quarters since. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Catalyst Financial Partners held 4,495 shares of Colgate-Palmolive worth $383K as of Q1 2026.
  • Catalyst Financial Partners bought 1,113 Colgate-Palmolive shares in Q1 2026, an estimated $99.2K.
  • Colgate-Palmolive made up 0.05% of Catalyst Financial Partners's portfolio in Q1 2026, its #245 holding.
  • Catalyst Financial Partners first reported a position in Colgate-Palmolive in Q2 2023 and has held it in 12 quarters since.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Catalyst Financial Partners's 13F filing for Q1 2026, filed 12 May 2026.